Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | MMP1 | P03956 | 1/20 | 0.36 |
| ▸ | MMP2 | P08253 | 1/20 | 0.36 |
| ▸ | MMP3 | P08254 | 1/20 | 0.36 |
| ▸ | MMP9 | P14780 | 1/20 | 0.36 |
| ▸ | MMP13 | P45452 | 1/20 | 0.36 |
| ▸ | PRKCA | P17252 | 2/20 | 0.33 |
| ▸ | ALDH1A1 | P00352 | 1/20 | 0.33 |
| ▸ | TDP1 | Q9NUW8 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.31 |
| ▸ | PRKD3 | O94806 | 1/20 | 0.31 |
| ▸ | PRKCG | P05129 | 1/20 | 0.31 |
| ▸ | PRKCB | P05771 | 1/20 | 0.31 |
| ▸ | PRKCH | P24723 | 1/20 | 0.31 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
| ▸ | PRKCE | Q02156 | 1/20 | 0.31 |
| ▸ | PRKCQ | Q04759 | 1/20 | 0.31 |
| ▸ | PRKCZ | Q05513 | 1/20 | 0.31 |
| ▸ | PRKCD | Q05655 | 1/20 | 0.31 |
| ▸ | PRKD1 | Q15139 | 1/20 | 0.31 |
| ▸ | GLA | P06280 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL98537 | 0.94 | MAPK1 (0.31) | PRKCA | |
| SCHEMBL25709485 | 0.91 | MMP1 (0.33) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL8216917 | 0.90 | MMP1 (0.42) | MMP1MMP2MMP3MMP9MMP13 | |
| SCHEMBL869642 | 0.89 | ALDH1A1 (0.37) | PRKCAALDH1A1 | |
| SCHEMBL25709316 | 0.89 | ALDH1A1 (0.37) | PRKCAALDH1A1 | |
| SCHEMBL868170 | 0.89 | — | — | |
| SCHEMBL869409 | 0.89 | ALDH1A1 (0.41) | PRKCAALDH1A1 | |
| SCHEMBL25011702 | 0.87 | — | — | |
| SCHEMBL13129066 | 0.87 | — | — | |
| SCHEMBL868957 | 0.86 | ALDH1A1 (0.37) | ALDH1A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 3 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20230202976-A1 | METHOD FOR PRODUCING THIOL COMPOUND | SHOWA DENKO K.K. (JP) | 2023-06-29 | — | — | US | disclosed |
| US-9957376-B2 | Optical material composition and use thereof | ETERNAL MATERIALS CO., LTD. (TW) | 2018-05-01 | — | — | US | disclosed |
| US-20160312009-A1 | OPTICAL MATERIAL COMPOSITION AND USE THEREOF | ETERNAL MATERIALS CO., LTD. (TW) | 2016-10-27 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20230202976-A1 | METHOD FOR PRODUCING THIOL COMPOUND | TST, TMT1A, MPST | MMP1 3974/4885MMP2 4411/4885MMP3 4429/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.